AbCellera

Share on: 
Website: AbCellera
Description: 

Develop therapeutic monoclonal antibodies. 

3/12/2020 - AbCellera and Lilly will select from 500+ unique antibodies isolated from one of the first U.S. patients who recovered from COVID-19 to create antibody therapeutics for treatment and prevention of COVID-19

Career Page(s): 
Location(s): 
Vancouver
Canada